These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081 [TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
6. Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids. Kuramoto K; Wang N; Fan Y; Zhang W; Schoenen FJ; Frankowski KJ; Marugan J; Zhou Y; Huang S; He C Autophagy; 2016 Sep; 12(9):1460-71. PubMed ID: 27305347 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550 [TBL] [Abstract][Full Text] [Related]
8. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC. Lile JA; Kelly TH; Hays LR Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. DeLong GT; Wolf CE; Poklis A; Lichtman AH Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
11. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572 [TBL] [Abstract][Full Text] [Related]
12. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107 [TBL] [Abstract][Full Text] [Related]
13. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Vara D; Salazar M; Olea-Herrero N; Guzmán M; Velasco G; Díaz-Laviada I Cell Death Differ; 2011 Jul; 18(7):1099-111. PubMed ID: 21475304 [TBL] [Abstract][Full Text] [Related]
15. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice. Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095 [TBL] [Abstract][Full Text] [Related]
16. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids. Janoyan JJ; Crim JL; Darmani NA Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518 [TBL] [Abstract][Full Text] [Related]
17. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use. Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544 [TBL] [Abstract][Full Text] [Related]
18. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence. Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans. Skosnik PD; Hajós M; Cortes-Briones JA; Edwards CR; Pittman BP; Hoffmann WE; Sewell AR; D'Souza DC; Ranganathan M Neuropharmacology; 2018 Jun; 135():412-423. PubMed ID: 29604295 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]